Aspirin cuts risk of death in cancer patients by 20%, study shows
Painkiller is ‘not a possible alternative to any other treatment’ on its own, researchers stress
Cancer patients who take aspirin alongside their treatment could cut their risk of death by 20 per cent, a review has suggested.
While stressing that it is “not a possible alternative to any other treatment”, scientists said that the medication has “biological mechanisms” that help reduce mortality risk, as well as stopping the spread of cancer within the body.
The researchers said the common painkiller could reduce the risk of death in colon, breast and prostate cancer patients, adding that “serious consideration” could be given to using the medications in conjunction with other therapies to treat cancer.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies